Frontlight ResearchEarly access
Childhood cancers trials in United States
933 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleLurbinectedin in FET-Fused Tumors
- Where
- Ann Arbor, Boston, Iowa City, Los Angeles, New York, Philadelphia
- Age
- 10 years and over
- People
- 63
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT05918640 - No phaseTaking peopleA Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
- Where
- Los Angeles
- People
- 1,500
- Run by
- Jonsson Comprehensive Cancer Center
See details and how to joinNCT06568016 - Phase 3Taking peopleAccelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
- Where
- Baltimore, Boston, Chicago, Columbus, Corpus Christi, Dallas, Downey, Loma Linda, Long Beach, Los Angeles, New York, Oak Lawn, Palo Alto, Park Ridge, Salt Lake City, San Antonio, San Diego, St Louis
- Age
- 11 years to 50 years
- People
- 500 worldwide
- Run by
- University of Sydney
See details and how to joinNCT02582697 - Phase 1Taking peopleLosartan + Sunitinib in Treatment of Osteosarcoma
- Where
- Atlanta, Aurora, Los Angeles
- Age
- 10 years and over
- People
- 41
- Run by
- University of Colorado, Denver
See details and how to joinNCT03900793 - Phase 2Taking peopleStudy of Olutasidenib and Temozolomide in HGG
- Where
- Aurora, Boston, Chicago, Cincinnati, Columbus, Durham, Houston, Miami, Philadelphia, Seattle, Washington D.C.
- Age
- 12 years to 39 years
- People
- 60 worldwide
- Run by
- Rigel Pharmaceuticals
See details and how to joinNCT06161974 - Phase 1Taking peopleAutologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies
- Where
- Palo Alto
- Age
- 1 year to 25 years
- People
- 28
- Run by
- Stanford University
See details and how to joinNCT06408194 - Phase 1Taking peopleGenetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial
- Where
- Seattle
- Age
- 1 year to 75 years
- People
- 30
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT07227571 - No phaseTaking peopleRelapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study
- Where
- Houston
- Age
- 3 years to 50 years
- People
- 300
- Run by
- Mohammad H. Abu Arja
See details and how to joinNCT07242963 - Phase 1Taking peopleStudy of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
- Where
- Memphis
- Age
- Up to 21 years
- People
- 60
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT04881240 - Phase 3Taking peopleTriptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
- Where
- Akron, Albany, Albuquerque, Alton, Ankeny, Ann Arbor, Atlanta, Aurora, Ballwin, Battle Creek, Bethesda, Birmingham, Bismarck, Bolivar, Branson, Cape Girardeau, Carroll, Centralia, Chadds Ford, Chapel Hill, Charleston, Chicago, City of Saint Peters, Cleveland, Clive, Columbia, Columbus, Creston, Creve Coeur, Dallas, Danville, Dayton, DeKalb, Denver, Des Moines, Duarte, Durham, Effingham, Elkton, El Paso, Fargo, Fort Dodge, Fort Myers, Fort Smith, Fort Worth, Gainesville, Garden City, Geneva, Glenview, Grand Rapids, Grayslake, Great Bend, Green Bay, Hackensack, Hartford, Hershey, Hollywood, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Joplin, Kalamazoo, Kansas City, La Jolla, Lake Forest, Lewes, Little Rock, Loma Linda, Los Angeles, Louisville, Madison, Mattoon, Memphis, Miami, Millville, Milwaukee, Minneapolis, Mobile, Mount Vernon, Muskegon, Nashville, Newark, New Orleans, New York, Niles, Normal, Norton Shores, Oakland, Oak Lawn, Oconto Falls, Oklahoma City, Omaha, Orange, Orlando, Orland Park, Osage Beach, Park Ridge, Pella, Pensacola, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Reed City, Rehoboth Beach, Richmond, Roanoke, Rochester, Rolla, Sacramento, Saint Joseph, San Antonio, San Diego, Scarborough, Seattle, Sheboygan, Shiloh, Sioux Falls, Spokane, Springfield, St Louis, Stony Brook, Sturgeon Bay, Tacoma, Tampa, The Bronx, Traverse City, Tucson, Urbana, Warrenville, Washington, Washington D.C., Waukee, West Des Moines, West Palm Beach, Wilmington, Winston-Salem, Wyoming, Yorkville
- Age
- Up to 39 years
- People
- 60 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT06513962 - Phase 2Taking peoplePhase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL
- Where
- Houston
- Age
- 2 years to 21 years
- People
- 15
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07551583 - No phaseNot yet taking people in United StatesPedi-STAR: Surface Target Antibody-drug Conjugate (ADC) Antigen Expression in Relapsed/Refractory Pediatric Solid and CNS Tumors
- Where
- Boston
- Age
- Up to 30 years
- People
- 130
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT07793994 - No phaseTaking peopleAuditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves
- Where
- New York
- Age
- 18 months to 21 years
- People
- 20
- Run by
- NYU Langone Health
See details and how to joinNCT02310399 - Phase 2Taking peopleN10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
- Where
- New York
- Age
- 18 months to 19 years
- People
- 45
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06528496 - Phase 1Taking peopleCD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
- Where
- Memphis
- Age
- Up to 21 years
- People
- 70
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT07257419 - No phaseTaking peopleFluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
- Where
- San Francisco
- Age
- 4 years and over
- People
- 199
- Run by
- Thomas Hope
See details and how to joinNCT06474533 - Phase 1Taking peopleEx Vivo Drug Sensitivity Testing and Multi-Omics Profiling
- Where
- Miami
- Age
- 1 day to 21 years
- People
- 65
- Run by
- Florida International University
See details and how to joinNCT05857969 - No phaseNot yet taking people in United StatesTumor-Lymph Node Mapping
- Where
- Rochester
- Age
- 1 month to 17 years
- People
- 10
- Run by
- University of Rochester
See details and how to joinNCT07054944 - No phaseTaking peopleFatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors
- Where
- Cleveland
- Age
- 5 years to 50 years
- People
- 120
- Run by
- Case Comprehensive Cancer Center
See details and how to joinNCT07114614 - No phaseTaking peopleBridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention
- Where
- Boston
- Age
- 15 years to 39 years
- People
- 40
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT07662239 - No phaseTaking peopleProject: Every Child for Younger Patients With Cancer
- Where
- Akron, Albany, Albuquerque, Allentown, Amarillo, Anchorage, Ann Arbor, Asheville, Atlanta, Augusta, Aurora, Austin, Baltimore, Bangor, Battle Creek, Bethesda, Bethlehem, Birmingham, Boise, Boston, Brooklyn, Buffalo, Burlington, Chapel Hill, Charleston, Charlotte, Charlottesville, Chattanooga, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Denver, Des Moines, Detroit, Downey, Duarte, Durham, East Lansing, Effingham, El Paso, Falls Church, Fargo, Flint, Fort Lauderdale, Fort Myers, Fort Sam Houston, Fort Worth, Gainesville, Grand Rapids, Green Bay, Greenville, Hackensack, Hartford, Henderson, Hershey, Hollywood, Honolulu, Houston, Huntington, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Kingman, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Loxahatchee Groves, Lubbock, Macon, Madera, Madison, Marshfield, Mattoon, Maywood, McAllen, Memphis, Mesa, Miami, Milwaukee, Mineola, Minneapolis, Mobile, Morgantown, Morristown, Muskegon, Nashville, Neptune City, Newark, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Niles, Norfolk, Normal, Norton Shores, Oakland, Oak Lawn, Oklahoma City, Omaha, Orange, Orlando, Pahrump, Palo Alto, Park Ridge, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Portsmouth, Providence, Reed City, Reno, Richmond, Roanoke, Rochester, Royal Oak, Sacramento, Saint Joseph, Salt Lake City, San Antonio, San Diego, San Francisco, Santa Barbara, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, Springfield, St Louis, Stony Brook, St. Petersburg, Syracuse, Tacoma, Tampa, Temple, The Bronx, Toledo, Torrance, Traverse City, Tucson, Tulsa, Urbana, Valhalla, Washington D.C., West Palm Beach, Wichita, Wilmington, Winfield, Winston-Salem, Worcester, Wyoming, Yorkville
- Age
- Up to 25 years
- People
- 75,000 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT02402244 - Phase 3Taking peopleActive Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- Where
- Aberdeen, Abington, Akron, Albany, Albuquerque, Allentown, Amarillo, Anaheim, Anchorage, Ankeny, Ann Arbor, Arroyo Grande, Asheville, Athens, Atlanta, Augusta, Aurora, Austin, Baltimore, Bangor, Bardstown, Battle Creek, Bellevue, Bellflower, Bellingham, Belpre, Bend, Berlin Corners, Bethesda, Bethlehem, Birmingham, Bloomington, Boiling Springs, Boise, Bonne Terre, Boston, Brewer, Bridgeport, Brooklyn, Bryan, Buffalo, Burbank, Burien, Burlington, Canton, Cape Girardeau, Carbondale, Carmel, Carmichael, Carson City, Carterville, Carthage, Centralia, Chapel Hill, Charleston, Charlotte, Charlottesville, Chattanooga, Chicago, Chillicothe, Cincinnati, Clackamas, Cleveland, Clinton, Clive, Colorado Springs, Columbia, Columbus, Coos Bay, Corbin, Corpus Christi, Council Bluffs, Creston, Dallas, Danville, Dayton, Decatur, Delaware, Denver, Des Moines, Detroit, Dixon, Downey, Duarte, Dublin, Duluth, Durango, Durham, East Lansing, Edmonds, Effingham, Elk Grove, El Paso, Enumclaw, Escanaba, Eureka, Evanston, Evansville, Everett, Fargo, Farmington, Federal Way, Flint, Fontana, Fort Collins, Fort Lauderdale, Fort Myers, Fort Worth, Fruitland, Gaffney, Gainesville, Galesburg, Glens Falls, Glenview, Golden, Goldsboro, Grand Island, Grand Rapids, Greeley, Green Bay, Greenville, Greer, Grove City, Hackensack, Hartford, Henderson, Hershey, Highland Park, Hixson, Hollywood, Honolulu, Hot Springs, Houston, Huntersville, Huntington, Indianapolis, Iowa City, Issaquah, Jackson, Jacksonville, Jefferson City, Johnson Creek, Kalamazoo, Kansas City, Kearney, Kennewick, Kewanee, Kingman, Knoxville, Lacey, La Jolla, Lakewood, Las Vegas, Lawton, Lebanon, Lexington, Lima, Lincoln, Little Rock, Littleton, Loma Linda, London, Lone Tree, Long Beach, Longmont, Longview, Los Angeles, Louisville, Loveland, Lubbock, Macomb, Macon, Madera, Madison, Manitowoc, Mansfield, Marietta, Marinette, Marion, Marshfield, Martinsburg, Marysville, Matthews, Mattoon, Maywood, Medford, Memphis, Meridian, Mesa, Miami, Milwaukee, Mineola, Minneapolis, Missoula, Mobile, Mooresville, Morgantown, Morristown, Mount Sterling, Mount Vernon, Muskegon, Nampa, Napa, Nashville, Neptune City, Newark, Newberg, New Brunswick, Newburgh, New Haven, New Hyde Park, New Orleans, Newport Beach, New York, Niles, Norfolk, Oakland, Oak Lawn, Oconto Falls, O'Fallon, Oklahoma City, Omaha, Ooltewah, Orange, Oregon City, Orlando, Osage Beach, Ottawa, Pahrump, Palo Alto, Papillion, Parker, Parkersburg, Park Ridge, Paterson, Pekin, Pensacola, Peoria, Perrysburg, Peru, Philadelphia, Phoenix, Pickerington, Pittsburgh, Port Huron, Portland, Portsmouth, Poulsbo, Princeton, Providence, Pueblo, Reed City, Reno, Richmond, Roanoke, Rochester, Rocklin, Roseville, Royal Oak, Sacramento, Sainte Genevieve, Saint Joseph, Salisbury, Salt Lake City, San Antonio, San Diego, San Francisco, San Luis Obispo, Santa Clara, Santa Maria, Santa Rosa, Savannah, Scarborough, Seattle, Seneca, Sheboygan, Shelton, Shepherdsville, Silverdale, Sioux Falls, Skokie, South Bend, Spartanburg, Spokane, Spokane Valley, Springfield, St Louis, Stony Brook, St. Petersburg, Sturgeon Bay, Sullivan, Swansea, Sylvania, Syracuse, Tacoma, Tampa, Temple, The Bronx, Thornton, Toledo, Torrance, Traverse City, Tucson, Tulsa, Twin Falls, Union, Urbana, Valhalla, Vancouver, Walla Walla, Washington, Washington D.C., Waukee, West Des Moines, Westerville, West Palm Beach, Wichita, Willow Grove, Wilmington, Winston-Salem, Woodland, Worcester, Wyoming, Yakima, Yelm, Yorkville, Zanesville
- People
- 1,780 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT03067181 - Phase 3Taking peopleTesting the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Where
- Albany, Albuquerque, Allentown, Ann Arbor, Asheville, Atlanta, Aurora, Austin, Baltimore, Bangor, Bethesda, Birmingham, Boise, Boston, Brooklyn, Buffalo, Burlington, Chapel Hill, Charleston, Charlotte, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Denver, Des Moines, Detroit, Downey, Durham, East Lansing, El Paso, Fargo, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Green Bay, Greenville, Hackensack, Hartford, Hershey, Hollywood, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Los Angeles, Lubbock, Madera, Madison, Marshfield, Memphis, Miami, Milwaukee, Mineola, Minneapolis, Morgantown, Morristown, Nashville, Newark, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Oakland, Oak Lawn, Oklahoma City, Omaha, Orange, Orlando, Palo Alto, Park Ridge, Paterson, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Richmond, Rochester, Royal Oak, Sacramento, Salt Lake City, San Antonio, San Diego, San Francisco, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, Springfield, St Louis, Stony Brook, St. Petersburg, Syracuse, Tacoma, The Bronx, Toledo, Valhalla, Washington D.C., West Palm Beach, Wilmington, Winston-Salem
- Age
- 365 days to 30 years
- People
- 750 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT03126916 - Phase 3Taking peopleInotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- Where
- Akron, Albany, Albuquerque, Allentown, Amarillo, Anchorage, Ann Arbor, Asheville, Atlanta, Augusta, Aurora, Austin, Baltimore, Bangor, Bethesda, Birmingham, Boise, Boston, Brooklyn, Buffalo, Burlington, Chapel Hill, Charleston, Charlotte, Charlottesville, Chattanooga, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Denver, Des Moines, Detroit, Downey, Duarte, Durham, East Lansing, El Paso, Falls Church, Fargo, Fort Lauderdale, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Green Bay, Greenville, Hackensack, Hartford, Hershey, Hollywood, Honolulu, Houston, Huntington, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Loxahatchee Groves, Lubbock, Macon, Madera, Madison, Marshfield, Maywood, McAllen, Mesa, Miami, Milwaukee, Mineola, Minneapolis, Mobile, Morgantown, Morristown, Nashville, Neptune City, Newark, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Norfolk, Oakland, Oak Lawn, Oklahoma City, Omaha, Orange, Orlando, Palo Alto, Park Ridge, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Portsmouth, Providence, Reno, Richmond, Roanoke, Rochester, Royal Oak, Sacramento, Salt Lake City, San Antonio, San Diego, San Francisco, Santa Barbara, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, Springfield, St Louis, Stony Brook, St. Petersburg, Syracuse, Tacoma, Tampa, Temple, The Bronx, Toledo, Torrance, Tucson, Tulsa, Valhalla, Washington D.C., West Palm Beach, Wichita, Wilmington, Winfield, Winston-Salem, Worcester
- Age
- 365 days to 25 years
- People
- 5,951 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT03959085 - Phase 2Taking peopleA Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- Where
- Akron, Albany, Albuquerque, Allentown, Amarillo, Anchorage, Ann Arbor, Asheville, Atlanta, Augusta, Aurora, Austin, Baltimore, Bangor, Birmingham, Boise, Boston, Buffalo, Charleston, Charlotte, Charlottesville, Chattanooga, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Denver, Des Moines, Detroit, Downey, Durham, East Lansing, El Paso, Falls Church, Fargo, Fort Lauderdale, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Green Bay, Greenville, Hackensack, Hartford, Hershey, Hollywood, Honolulu, Houston, Huntington, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Lubbock, Macon, Madera, Madison, Marshfield, Maywood, Memphis, Mesa, Miami, Milwaukee, Minneapolis, Mobile, Morristown, Nashville, Newark, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Norfolk, Oakland, Oak Lawn, Oklahoma City, Omaha, Orange, Orlando, Palo Alto, Park Ridge, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Reno, Richmond, Roanoke, Rochester, Royal Oak, Sacramento, Salt Lake City, San Antonio, San Diego, San Francisco, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, Springfield, St Louis, Stony Brook, St. Petersburg, Syracuse, Tacoma, Tampa, The Bronx, Toledo, Tucson, Valhalla, Washington D.C., West Palm Beach, Wilmington, Winston-Salem, Worcester
- Age
- Up to 30 years
- People
- 256 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT04322318